Description of "Client" in Outside Counsel Guidelines Prohibits Representation Adverse to Affiliates of Firm's Current Client
Lawyers for the Profession® Alert | 2 min read
Mar 21, 2019
Falk Pharma GMBH v. Generico, LLC, Nos. 2017-2312, 2017-2636, 2018-1320, 2018-2097, 2019 U.S. App. LEXIS 4859 (Fed. Cir. Feb. 8, 2019)
Brief Summary
The U.S. Court of Appeals for the Federal Circuit has ruled that a law firm must withdraw from representing a company in patent appeals because the law firm had an ongoing attorney-client relationship with an affiliate of adverse parties in the litigation. The court found that the affiliate's Outside Counsel Guidelines, incorporated by reference in the engagement letter, created an attorney-client relationship with the adverse parties in the patent appeals, which required disqualification.
Complete Summary
This matter came before the U.S. Court of Appeals for the Federal Circuit on motions to disqualify Katten Muchin Rosenman LLP ("Katten") as counsel for Mylan Pharmaceuticals Inc. ("Mylan") in three appeals: Valeant Pharmaceuticals International, Inc. ("Valeant-CA") and Salix Pharmaceuticals, Inc. ("Salix") moved to disqualify in Valeant Pharmaceuticals International, Inc. v. Mylan Pharmaceuticals Inc., No. 2018-2097 ("Valeant II"); Salix moved to disqualify in Salix Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Nos. 2017-2636, 2018-1320 ("Salix II"); and Valeant-CA and Salix moved to disqualify in Dr. Falk Pharma GmbH v. GeneriCo, LLC, No. 2017-2312 ("Dr. Falk II"). The attorneys from Katten who represented Mylan were lateral partners of Katten who had commenced the representation while partners at Alston & Bird LLP.
Katten currently represented Bausch & Lomb, a corporate affiliate of Valeant-CA and Salix, in trademark litigation. Valeant-CA and Salix asserted that Katten should be disqualified from representing Mylan in these appeals because it had an attorney-client relationship with Valeant-CA and Salix as a consequence of its representation of Bausch & Lomb, creating a concurrent conflict of interest.
Katten had signed an engagement letter with Bausch & Lomb that governed "the overall relationship between [Katten] and Valeant Pharmaceuticals International, Inc."—i.e., Valeant-CA. This engagement letter referenced Valeant's Outside Counsel Guidelines ("Guidelines"). The Guidelines stated they "govern the relationship between Valeant Pharmaceuticals International [i.e., Valeant DE], its subsidiaries and affiliates … and outside counsel." The Guidelines did not define "conflict of interest," but stated that "Valeant expects its firms to adhere to local rules and ethics rules relating to conflict of interest and client representation."
In analyzing the issue of whether Katten should be disqualified from representing Mylan, the Federal Circuit applied regional circuit law. The relevant regional circuits in all three appeals apply the Model Rules of Professional Conduct, and thus, all three motions alleged violations of the same rule—Rule 1.7(a) of the Model Rules of Professional Conduct.
The court ultimately held that Katten had an ongoing attorney-client relationship with Valeant-CA and its subsidiaries, including Salix, based on the language of the engagement letter and the Guidelines. Further, the court concluded that Katten's representation of Mylan in the three subject appeals created concurrent conflicts of interest as Mylan was adverse to Valeant-CA and Salix.[1] Therefore, the circuit granted the motions to disqualify.
Significance of Decision
A broadly worded description of the attorney-client relationship in an engagement letter or Outside Counsel Guidelines may create an unintended attorney-client relationship with entities a firm does not represent. Law firms should use caution when considering engagement agreements which incorporate Outside Counsel Guidelines that may include a client's affiliates. Firms should also continuously update their conflicts database to reflect changes to corporate families, and vet potential lateral hires for similar issues.
[1] The court also found that Valeant-CA, Salix and Bausch & Lomb were sufficiently interrelated to give rise to a corporate affiliate conflict, adopting the reasoning of GSI Commerce Solutions, Inc. v. BabyCenter, L.L.C., 618 F.3rd 204 (2d Cir. 2010).
Featured Insights

Press Release
May 20, 2026
Hinshaw Releases America 250 Book Exploring Insurance's Role in Building the United States

Consumer Crossroads: Where Financial Services and Litigation Intersect
May 19, 2026
OCC's Final Escrow-Interest Preemption Rules Bolster the Second Circuit’s Cantero Decision

Webinar
May 19, 2026
Scott Seaman Speaks on Making Decisions in Difficult Risk Environments

Consumer Crossroads: Where Financial Services and Litigation Intersect
May 14, 2026
Key Takeaways from the 2026 MBA Legal Issues and Regulatory Compliance Conference

Consumer Crossroads: Where Financial Services and Litigation Intersect
May 14, 2026
SCOTUS Confirms: Federal Courts Retain Power to Affirm or Vacate an Arbitration Decision

In The News
May 13, 2026
Hinshaw Contributes Chapters to “Wrongful-Death and Survival Actions” IICLE Handbook

In The News
May 12, 2026
Hinshaw GC Steve Puiszis Discusses Protecting Attorney-Client Privilege in an AI Age

Event
May 12-13, 2026
Mitchel Chargo Speaks on the Rapidly Evolving Cannabis Industry

Consumer Crossroads: Where Financial Services and Litigation Intersect
May 11, 2026
Tennessee Reaches Settlement with Mariner in Multistate UDAAP Enforcement Action

Press Release
May 11, 2026
Ali Degan Elected to the Fellows of the American Bar Foundation

Press Release
May 11, 2026
John Weedon Re-Elected to the Jacksonville Bar Association’s Board of Governors in 2026


